A10BD05 • pioglitazone + metformin • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs
The combination of pioglitazone and metformin is used in the treatment of type 2 diabetes to improve glycemic control. Pioglitazone works by increasing insulin sensitivity, while metformin reduces hepatic glucose production and improves glucose utilization by muscles.
The medication is taken orally, as directed by a doctor, usually once or twice daily with meals. It is important for patients to follow the treatment regimen and adopt a healthy lifestyle, including a balanced diet and regular exercise.
Patients should be aware of potential side effects, such as nausea, diarrhea, or weight gain. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, diarrhea, and weight gain. In rare cases, severe reactions such as lactic acidosis or liver failure may occur. Patients should be informed of these risks before use.
Substance: pioglitazone + metformin
Date of last drug list: 01-05-2018
Commercial code: W64228008
Concentration: 15mg / 850mg
Pharmaceutical form: tablets
Quantity: 98
Product type: generic
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.